Melatonin counteracts the inhibitory effect of PGE 2 on IL‐2 production in human lymphocytes via its mt1 membrane receptor
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
It is well known that melatonin plays a fundamental role in human neuro‐immunomodulation. Thus, melatonin regulates the production of a large number of cytokines, including interleukin‐2 (IL‐2) in the human system. Both membrane and nuclear receptors for melatonin are present in lymphoid cells. However, most of these effects have been shown to be mediated by the putative nuclear receptor for the neurohormone. In this paper, we show that prostaglandin E 2 (PGE 2 ), a potent inflammatory mediator, inhibits IL‐2 production in human lymphocytes by a cyclic AMP (cAMP)‐dependent mechanism. In this model, melatonin counteracts the effects of PGE 2 on IL‐2 and cAMP production. We propose that the effect of melatonin is mediated by a membrane receptor, since similar results were obtained when cells were cultured in the presence of S 20098, a specific melatonin membrane receptor agonist. No effect was observed by using CGP 52608, a nuclear receptor agonist. Moreover, when cells were stimulated with phorbol myristate acetate (PMA), which has been shown to inhibit mt1 melatonin membrane receptor expression, the neurohormone failed to counteract the effect of PGE 2 . Therefore, we postulate, for the first time, a physiological role of the mt1 melatonin membrane receptor in the human immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*
REITER, R. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-151 · Cited by 2,192
The aging immune system: primer and prospectus
Miller, R. A. (1996) · Science · doi:10.1126/science.273.5271.70 · Cited by 1,165 · cited 1×
“Subsequently age-related changes in T and B lymphocytes are seen, such as a decrease in T and B cell proliferation, repertoire degeneracy, decline in virgin or reactive T cells, increase in memory or primed T cells, a shift from T helper 1 responses to T helper 2 response, and decrease of IL-2 by T cells, a key fa…”
BackgroundReppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096 · cited 2×
“Currently, two melatonin membrane receptors, mt1 and MT2 (36, 41), have been widely studied, whereas a third receptor, MT3, has been recently characterized (42).”
BackgroundMethod
Cited by
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
Functional MT1 and MT2 Melatonin Receptors in Mammals
Dubocovich, M. L., & Markowska, M. (2005) · Endocrine · doi:10.1385/endo:27:2:101 · Cited by 812
Melatonin: Buffering the Immune System
Carrillo-Vico, A., Lardone, P., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048638 · Cited by 740
Self-citationA Review of the Multiple Actions of Melatonin on the Immune System
Carrillo-Vico, A., Guerrero, J. M., Lardone, P. J., & Reiter, R. J. (2005) · Endocrine · doi:10.1385/endo:27:2:189 · Cited by 666
Self-citationMauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Dubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 621
A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes
Tomás‐Zapico, C., & Coto‐Montes, A. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00248.x · Cited by 503
Melatonin and the ovary: physiological and pathophysiological implications
Tamura, H., Nakamura, Y., Korkmaz, A., Manchester, L. C., Tan, D.-X., Sugino, N., & Reiter, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.05.016 · Cited by 468
Carrillo‐Vico, A., Calvo, J. R., Abreu, P., Lardone, P. J., García‐Mauriño, S., Reiter, R. J., & Guerrero, J. M. (2004) · The FASEB Journal · doi:10.1096/fj.03-0694fje · Cited by 458
Self-citationMelatonin and inflammation-Story of a double-edged blade
Hardeland, R. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12525 · Cited by 455
The role of melatonin in the cells of the innate immunity: a review
Calvo, J. R., González‐Yanes, C., & Maldonado, M. D. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12075 · Cited by 412
Self-citationLymphocytes as a neural probe: potential for studying psychiatric disorders
Gladkevich, A., Kauffman, H. F., & Korf, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.009 · Cited by 360
Aging, melatonin, and the pro- and anti-inflammatory networks
Hardeland, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051223 · Cited by 337
Melatonin: an inhibitor of breast cancer
Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A., Lundberg, P. W., Summers, W., Yuan, L., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0030 · Cited by 317
Hardeland, R. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12090 · Cited by 284
Hardeland, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8001-x · Cited by 253
Melatonin, immune function and aging
Srinivasan, V, Maestroni, G., Cardinali, D., Esquifino, A., Perumal, S. P., & Miller, S. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-17 · Cited by 242
“[125].”
Melatonin as an anti-inflammatory agent modulating inflammasome activation
Favero, G., Franceschetti, L., Bonomini, F., Rodella, L. F., & Rezzani, R. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1835195 · Cited by 233
Carrillo‐Vico, A., Lardone, P. J., Naji, L., Fernández‐Santos, J. M., Martín‐Lacave, I., Guerrero, J. M., & Calvo, J. R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00265.x · Cited by 204
Self-citationMartino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
“Agomelatine, a novel melatonergic MT1 and MT2 receptors agonist and a 5-HT2C receptor antagonist [354], seems to stimulate IL-2 production, like melatonin, via MT1 receptor agonism in human lymphocytes [355]; chronic administration modulates chronobiological rhythms, including temporal organization of cortisol secreti…”
Background
Metadata
- Authors
- Carrillo‐Vico, A., García‐Mauriño, S., Calvo, J. R., & Guerrero, J. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-02-19
- Volume
- 17
- Issue
- 6
- Pages
- 755-757
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2021399303
- Cited by
- 125
- References
- 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.